Search - tctmd.com

Displaying 61 - 80 of 375

Sort: Relevancy | Date

News Conference News CRT 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

L.A. McKeown

February 25, 2020

News Daily News

SYNTAX Score Predicts Long-term Benefits of Left Main PCI and CABG: MAIN-COMPARE

Michael O'Riordan

February 03, 2020

News Daily News

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Michael O'Riordan

December 10, 2019

News Features

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Yael L. Maxwell

November 27, 2019

Presentation TCT 2019

Patient Preferences in Hypertension Treatment

Presenter: David Kandzari

September 28, 2019

Presentation TCT 2019

The Challenges and Hazards of Re-Intervention and Stenting

Presenter: David Kandzari

September 28, 2019

Presentation TCT 2019

Some Stents Are More Equal Than Others (e.g., Ultra-Thin)!

Presenter: David Kandzari

September 27, 2019

Presentation TCT 2019

The Target BP Program: Ongoing and Future Studies

Presenter: David Kandzari

September 27, 2019

Presentation TCT 2019

Two Case Presentations Highlighting Relevant Patients

Presenter: David Kandzari

September 26, 2019

Opening Debate: Which Metallic DES Should Be on My Cath Lab Shelf? - Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presentation TCT 2019

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presenter: David Kandzari

September 26, 2019

Presentation TCT 2019

Potential Hazards of Re-Stenting

Presenter: David Kandzari

September 26, 2019

News Conference News ESC 2019

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

Caitlin E. Cox

September 10, 2019

Presentation CHIP Seattle 2019

Complex Coronary Intervention Programs Dedication for Advancement

Presenter: David E. Kandzari

August 02, 2019

News Daily News

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

L.A. McKeown

June 19, 2019

Case and Technique Reviews: High-Risk PCI and Cardiogenic Shock – The Role of Hemodynamic Support

Presentation Fellows 2019

Catheter-Based Circulatory Support Opportunities for Indication Expansion and Technology Development

Presenter: David Kandzari

April 13, 2019

News Conference News CRT 2019

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

L.A. McKeown

March 06, 2019

News Daily News

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Michael O'Riordan

January 08, 2019

News Daily News

Procedural Success Increasing for CTO PCI in Europe, Despite More Complex Lesions

Yael L. Maxwell

October 15, 2018

News Conference News TCT 2018

Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation

Todd Neale

September 25, 2018

Presentation TCT 2018

Results and Update From the SPYRAL Hypertension Program (OFF-MED and ON-MED Trials)

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, David E. Kandzari

September 24, 2018

Advertisement

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

SYNTAX Score Predicts Long-term Benefits of Left Main PCI and CABG: MAIN-COMPARE

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Patient Preferences in Hypertension Treatment

The Challenges and Hazards of Re-Intervention and Stenting

Some Stents Are More Equal Than Others (e.g., Ultra-Thin)!

The Target BP Program: Ongoing and Future Studies

Two Case Presentations Highlighting Relevant Patients

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Potential Hazards of Re-Stenting

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

Complex Coronary Intervention Programs Dedication for Advancement

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

Catheter-Based Circulatory Support Opportunities for Indication Expansion and Technology Development

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Procedural Success Increasing for CTO PCI in Europe, Despite More Complex Lesions

Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation

Results and Update From the SPYRAL Hypertension Program (OFF-MED and ON-MED Trials)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content